CompletedPhase 2NCT02784535
Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)
Studying Rare autonomic nervous system disorder
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Vanderbilt University Medical Center
- Principal Investigator
- Cyndya A Shibao, MD, MDVanderbilt University Medical Center
- Intervention
- Atomoxetine(drug)
- Enrollment
- 48 enrolled
- Eligibility
- 40-80 years · All sexes
- Timeline
- 2016 – 2023
Study locations (2)
- Dysautonomic Center at NYU Langone Medical Center, New York, New York, United States
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
Collaborators
NYU Langone Health
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02784535 on ClinicalTrials.govOther trials for Rare autonomic nervous system disorder
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07089043A Study in Subjects With Neurogenic Orthostatic HypotensionCuraSen Therapeutics, Inc.
- RECRUITINGNANCT06841198Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord InjuryKessler Foundation
- RECRUITINGNANCT06694688Evaluation of the Contribution of Lower Limb and/or Abdominal Compression on Orthostatic HypotensionGérond'if
- RECRUITINGNANCT07195903The STAND-UP StudySt. Francis Hospital, New York
- RECRUITINGNANCT06587841Noninvasive Spinal Cord Stimulation for Early SCIUniversity of British Columbia
- RECRUITINGPHASE2NCT06188663SalT Supplementation in Older Adults With Orthostatic Intolerance DisordersUniversity of Galway
- RECRUITINGNANCT05908760CO2 Rebreathing in nOH: A Proof-of-Concept Pilot StudyUniversity of Calgary
- ACTIVE NOT RECRUITINGNCT06439498Frequency of Orthostatic Hypotension in Patients Who Underwent ColonoscopyAnkara University